SUBSCribe
logo
twitterlinkedininstagramUser Profile
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • Just what the doctor ordered

          The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon

          December 23, 2017
        • Nursing Back to Health

          A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

          Jash Kriplani - October 18, 2017
        • Bold and Bountiful

          Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics

          Kripa Mahalingam - July 11, 2017
        • A Bitter Pill

          Regulatory woes continue to pile up for pharma companies

          Kripa Mahalingam - May 12, 2017
        • A new prescription

          Tectonic changes in the US generic drugs market is causing  huge shifts in Indian pharma’s strategies as well 

          Team Outlook Business - December 17, 2015

        Latest Edition

        magcover
        March 12, 2021
        magcover
        February 26, 2021
        magcover
        February 12, 2021
        magcover
        January 29, 2021
        twitterlinkedininstagramUser Profile
        • BIG STORY
        • PERSPECTIVE
        • ENTERPRISE
        • STRATEGY
        • MARKETS
        • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C'EST LA VIE
        • MAGAZINE
        About us Contact usPrivacy PolicyTerms and ConditionsSitemap
        Copyright © 2019 Outlook Business!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.